Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

2-(4-(3-(1-(4-(2-aminopyrimidin-5-yl)phenyl)-1-cyclopropylethyl)-(1,2,4)oxadiazol-5-yl)pyrazol-1-yl)-N,N-dimethylacetamide MeSH Supplementary Concept Data 2025


MeSH Supplementary
2-(4-(3-(1-(4-(2-aminopyrimidin-5-yl)phenyl)-1-cyclopropylethyl)-(1,2,4)oxadiazol-5-yl)pyrazol-1-yl)-N,N-dimethylacetamide
Unique ID
C000597466
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C000597466
Entry Term(s)
BI 665915
Registry Numbers
0
Heading Mapped to
*Acetamides
*Oxadiazoles
Frequency
2
Note
an inhibitor of 5-lipoxygenase-activating protein; structure in first source
Source
J Med Chem. 2015 Feb 26;58(4):1669-90.
Date of Entry
2015/05/03
Revision Date
2015/05/03
2-(4-(3-(1-(4-(2-aminopyrimidin-5-yl)phenyl)-1-cyclopropylethyl)-(1,2,4)oxadiazol-5-yl)pyrazol-1-yl)-N,N-dimethylacetamide Preferred
BI 665915 Narrower
page delivered in 0.004s